FIRST MANHATTAN CO. LLC. - SEELOS THERAPEUTICS INC ownership

SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 114 filers reported holding SEELOS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.

Quarter-by-quarter ownership
FIRST MANHATTAN CO. LLC. ownership history of SEELOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,056
-84.6%
11,1750.0%0.00%
Q2 2023$13,354
+72.9%
11,1750.0%0.00%
Q1 2023$7,724
-19.7%
11,175
-21.2%
0.00%
Q4 2022$9,624
-31.3%
14,1750.0%0.00%
Q3 2022$14,000
-12.5%
14,175
-43.2%
0.00%
Q2 2022$16,000
-11.1%
24,967
+13.7%
0.00%
Q1 2022$18,000
-48.6%
21,9670.0%0.00%
Q4 2021$35,000
-32.7%
21,9670.0%0.00%
Q3 2021$52,000
-8.8%
21,9670.0%0.00%
Q2 2021$57,000
-5.0%
21,967
+80.5%
0.00%
Q1 2021$60,00012,1720.00%
Other shareholders
SEELOS THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
GENDELL JEFFREY L 4,933,024$4,133,0000.30%
ACUTA CAPITAL PARTNERS, LLC 295,896$248,0000.12%
Connacht Asset Management LP 231,551$194,0000.10%
Uniplan Investment Counsel, Inc. 1,564,605$1,310,0000.08%
AdvisorShares Investments LLC 358,796$301,0000.05%
1492 Capital Management LLC 99,819$84,0000.04%
Woodline Partners LP 2,803,230$2,349,0000.04%
Ikarian Capital, LLC 257,883$215,0000.03%
Sovereign Financial Group, Inc. 75,000$63,0000.02%
Aquatic Capital Management LLC 6,400$5,0000.01%
View complete list of SEELOS THERAPEUTICS INC shareholders